SPARC and neoplasm: In one study, expression of SPARC was not associated with patient prognosis (P = 0.13), although the authors report that patients whose tumour stroma expressed SPARC had shorter median survival than patients whose tumour stroma lacked this expression (15 months versus 30 months, resp., P < 0.001) [29].